Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Lapatinib | 0.1 | uM | 7 | 2500.00 | 1881.33 | 2382.00 | 3839.00 | 0.6205 | 0.2577 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 7 | 2500.00 | 1881.33 | 3339.00 | 3839.00 | 0.8698 | 0.7464 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 7 | 2500.00 | 1881.33 | 3494.00 | 3839.00 | 0.9101 | 0.8251 |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3860.00 | 3839.00 | 1.0055 | 1.0106 | |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 2500.00 | 1881.33 | 3876.00 | 3839.00 | 1.0096 | 1.0187 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 7 | 2500.00 | 1881.33 | 3755.00 | 3839.00 | 0.9781 | 0.9575 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 7 | 2500.00 | 1881.33 | 3873.00 | 3839.00 | 1.0089 | 1.0172 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 2500.00 | 1881.33 | 4001.00 | 3839.00 | 1.0422 | 1.0820 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 7 | 2500.00 | 1881.33 | 2887.00 | 3839.00 | 0.7520 | 0.5162 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 2500.00 | 1881.33 | 3940.00 | 3839.00 | 1.0263 | 1.0511 |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3971.00 | 3839.00 | 1.0344 | 1.0668 | |
| SK-BR-3 | 17-AAG | 3.1623 | uM | 7 | 2500.00 | 1881.33 | 1871.00 | 3839.00 | 0.4874 | -0.0053 |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3805.00 | 3839.00 | 0.9911 | 0.9828 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 1.00 | 3839.00 | 0.0003 | -0.9993 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3.00 | 3839.00 | 0.0008 | -0.9981 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3562.00 | 3839.00 | 0.9279 | 0.8596 | |
| SK-BR-3 | 17-AAG | 10 | uM | 7 | 2500.00 | 1881.33 | 1803.00 | 3839.00 | 0.4697 | -0.0405 |
| SK-BR-3 | 17-AAG | 0.0016596 | uM | 7 | 2500.00 | 1881.33 | 3695.00 | 3839.00 | 0.9625 | 0.9271 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 7 | 2500.00 | 1881.33 | 3694.00 | 3839.00 | 0.9622 | 0.9266 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 2500.00 | 1881.33 | 3657.00 | 3839.00 | 0.9526 | 0.9078 |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3720.00 | 3839.00 | 0.9690 | 0.9397 | |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 2500.00 | 1881.33 | 3111.00 | 3839.00 | 0.8104 | 0.6304 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 7 | 2500.00 | 1881.33 | 3842.00 | 3839.00 | 1.0008 | 1.0015 |
| SK-BR-3 | Linsitinib | 1 | uM | 7 | 2500.00 | 1881.33 | 3352.00 | 3839.00 | 0.8731 | 0.7530 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 7 | 2500.00 | 1881.33 | 2250.00 | 3839.00 | 0.5861 | 0.1900 |